Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy
Lentz, S. R., Misgav, M., Ozelo, M., Šalek, S. Z., Veljkovic, D., Recht, M., Cerqueira, M., Tiede, A., Brand, B., Mancuso, M. E., Seremetis, S., Lindblom, A., Martinowitz, U.Volume:
19
Language:
english
Journal:
Haemophilia
DOI:
10.1111/hae.12159
Date:
September, 2013
File:
PDF, 214 KB
english, 2013